Search

everythinglearnresearchcommunity

for

Search:↓

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Quercetin may help improve skin conditions in cats with Feline Atopic Skin Syndrome.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Blue light might help treat skin conditions by affecting the skin's bacteria.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Platelet-rich plasma (PRP) shows promise for treating melasma but needs more research for confirmation.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to safety and ease of use.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

People with alopecia areata had lower vitamin D levels, but these levels did not relate to how severe their condition was.

Yellow dots are common in severe alopecia areata.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

A new model uses specific blood markers to predict if children's hair loss will return.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Improved diagnosis and affordable topical treatments are essential for managing alopecia areata in India.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.